Detalhe da pesquisa
1.
Correlation between TXNRD1/HO-1 expression and response to neoadjuvant chemoradiation therapy in patients with esophageal squamous cell carcinoma.
Esophagus
; 19(3): 436-443, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34999996
2.
MMR markers correlate with clinical outcome in patients with esophageal squamous cell carcinoma.
Int J Biol Markers
; 38(2): 105-113, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37009661
3.
HO-1 in lymph node metastasis predicted overall survival in patients with esophageal squamous cell carcinoma receiving neoadjuvant chemoradiation therapy.
Cancer Rep (Hoboken)
; 5(3): e1477, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34264023
4.
Tumor Microenvironment in Mixed Neuroendocrine Non-Neuroendocrine Neoplasms: Interaction between Tumors and Immune Cells, and Potential Effects of Neuroendocrine Differentiation on the Tumor Microenvironment.
Cancers (Basel)
; 14(9)2022 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35565281
5.
Thoracoscopic esophagectomy for esophageal carcinoma after peroral endoscopic myotomy for esophageal achalasia: a case report.
Surg Case Rep
; 7(1): 186, 2021 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34410537
6.
Necroptosis in Esophageal Squamous Cell Carcinoma: An Independent Prognostic Factor and Its Correlation with Tumor-Infiltrating Lymphocytes.
Cancers (Basel)
; 13(17)2021 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34503283